Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Dr. Lisa PierceyIndependent Director | 949,00 | 174,86k | Achat | 184,26 | 949,00 | - |
| 2026-05-21 | Mr. Richard F. LaRocheIndependent Director | -7,50k | 1,46M | Vente | 195,14 | 359,88k | -2,04% |
| 2026-05-20 | Dr. Stephen Fowler FlattCEO, President & Director | -26,00 | 0,00 | Other Disposition | - | 66,99k | -0,04% |
| 2026-05-19 | Mr. Timothy J. ShellyInitié | -1,85k | 365,44k | Vente | 197,22 | 1,29k | -58,88% |
| 2026-05-14 | Dr. Stephen Fowler FlattCEO, President & Director | -4,49k | 470,02k | Derivative Exercise and Sale | 90,62 - 197,96 | 67,01k | - |
| 2026-05-14 | Dr. Stephen Fowler FlattCEO, President & Director | 1,51k | 141,90k | Derivative Exercise and Retained Stock | 94,10 | 67,01k | 2,30% |
| 2026-05-14 | Mr. Brian Frederick KiddSenior VP & CFO | 1,37k | 128,54k | Derivative Exercise and Retained Stock | 94,10 | 30,50k | 4,69% |
| 2026-05-14 | Mr. Brian Frederick KiddSenior VP & CFO | -3,13k | 327,24k | Derivative Exercise and Sale | 90,62 - 197,96 | 30,50k | - |
| 2026-05-06 | Ms. Sandra Y. TrailIndependent Director | 3,14k | 175,06k | Derivative Exercise and Retained Stock | 55,75 | 10,64k | 41,87% |
| 2026-05-05 | Mr. Richard F. LaRocheIndependent Director | 7,50k | 537,30k | Derivative Exercise and Retained Stock | 71,64 | 367,38k | 2,08% |
| 2026-04-30 | Mr. Emil E. HassanIndependent Director | 7,50k | 537,30k | Derivative Exercise and Retained Stock | 71,64 | 73,10k | 11,43% |
| 2026-04-22 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | 1,15k | 107,93k | Derivative Exercise and Retained Stock | 94,10 | 15,56k | 7,96% |
| 2026-04-22 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | -2,85k | 226,90k | Derivative Exercise and Sale | 94,10 - 173,63 | 15,56k | - |
| 2026-04-09 | Mr. B. Anderson FlattSenior VP & Chief Information Officer | -2,11k | 372,89k | Sale to Issuer | 176,81 | 21,18k | -9,06% |
| 2026-04-09 | Mr. B. Anderson FlattSenior VP & Chief Information Officer | 3,73k | 201,41k | Derivative Exercise and Retained Stock | 53,94 | 21,18k | 21,41% |
| 2026-03-16 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | 1,70k | 91,70k | Derivative Exercise and Retained Stock | 53,94 | 14,41k | 13,37% |
| 2026-03-16 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | -2,03k | 225,81k | Derivative Exercise and Sale | 53,94 - 164,96 | 14,41k | - |
| 2026-03-12 | Dr. Stephen Fowler FlattCEO, President & Director | 1,85k | 99,95k | Derivative Exercise and Retained Stock | 53,94 | 65,51k | 2,91% |
| 2026-03-12 | Mr. Brian Frederick KiddSenior VP & CFO | 1,85k | 99,95k | Derivative Exercise and Retained Stock | 53,94 | 29,13k | 6,79% |
| 2026-03-09 | Dr. James Paul AbernathyIndependent Director | 3,14k | 175,06k | Derivative Exercise and Retained Stock | 55,75 | 43,30k | 7,82% |
| 2026-03-04 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | 1,34k | 121,52k | Derivative Exercise and Retained Stock | 90,62 | 12,71k | 11,79% |
| 2026-03-04 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | -3,16k | 259,70k | Derivative Exercise and Sale | 90,62 - 172,83 | 12,71k | - |
| 2026-03-04 | Mr. B. Anderson FlattSenior VP & Chief Information Officer | 4,09k | 235,05k | Derivative Exercise and Retained Stock | 53,94 - 94,10 | 19,55k | 26,46% |
| 2026-03-04 | Mr. B. Anderson FlattSenior VP & Chief Information Officer | -8,14k | 656,68k | Derivative Exercise and Sale | 90,62 - 172,83 | 19,55k | - |
| 2026-03-04 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | 1,30k | 117,62k | Derivative Exercise and Retained Stock | 90,62 | 12,70k | 11,39% |
| 2026-03-04 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | -3,20k | 263,24k | Derivative Exercise and Sale | 90,62 - 172,83 | 12,70k | - |
| 2026-03-04 | Mr. Timothy J. ShellyInitié | 1,85k | 174,37k | Derivative Exercise and Retained Stock | 94,10 | 3,15k | 143,20% |
| 2026-03-04 | Mr. Timothy J. ShellyInitié | -4,48k | 365,55k | Derivative Exercise and Sale | 90,62 - 172,83 | 3,15k | - |
| 2026-03-04 | Mr. Brian Frederick KiddSenior VP & CFO | 2,05k | 112,68k | Derivative Exercise and Retained Stock | 53,94 - 90,62 | 27,28k | 8,14% |
| 2026-03-04 | Mr. Brian Frederick KiddSenior VP & CFO | -3,95k | 324,48k | Derivative Exercise and Sale | 90,62 - 172,83 | 27,28k | - |
| 2026-03-02 | Dr. Stephen Fowler FlattCEO, President & Director | 1,42k | 128,23k | Derivative Exercise and Retained Stock | 90,62 | 63,65k | 2,27% |
| 2026-03-02 | Dr. Stephen Fowler FlattCEO, President & Director | -3,59k | 288,70k | Derivative Exercise and Sale | 90,62 - 171,15 | 63,65k | - |
| 2026-01-15 | Dr. James Paul AbernathyIndependent Director | 3,77k | 263,08k | Derivative Exercise and Retained Stock | 69,82 | 40,16k | 10,35% |
| 2026-01-15 | Dr. James Paul AbernathyIndependent Director | -3,73k | 258,22k | Derivative Exercise and Sale | 69,82 - 139,01 | 40,16k | - |
| 2025-11-11 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | -496,00 | 68,40k | Sale to Issuer | 137,90 | 9,94k | -4,75% |
| 2025-12-31 | Mr. R. Michael UsseryInitié | -2,06k | 282,82k | Sale to Issuer | 137,09 | 158,46k | -1,29% |
| 2026-01-01 | Mr. B. Anderson FlattSenior VP & Chief Information Officer | -403,00 | 55,25k | Sale to Issuer | 137,09 | 14,12k | -2,78% |
| 2026-01-01 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | -319,00 | 43,73k | Sale to Issuer | 137,09 | 10,29k | -3,01% |
| 2026-01-01 | Mr. Brian Frederick KiddSenior VP & CFO | -447,00 | 61,28k | Sale to Issuer | 137,09 | 23,69k | -1,85% |
| 2025-01-01 | Dr. Stephen Fowler FlattCEO, President & Director | -1,02k | 140,38k | Sale to Issuer | 137,09 | 59,15k | -1,70% |
| 2025-12-29 | Dr. Stephen Fowler FlattCEO, President & Director | -450,00 | 0,00 | Other Disposition | - | 60,17k | -0,74% |
| 2025-12-23 | Mr. Brian Frederick KiddSenior VP & CFO | -350,00 | 0,00 | Other Disposition | - | 24,14k | -1,43% |
| 2025-12-17 | Mr. Timothy J. ShellyInitié | -2,45k | 342,14k | Vente | 139,42 | 0,00 | -100,00% |
| 2025-12-17 | Mr. R. Michael UsseryInitié | -1 000,00 | 0,00 | Other Disposition | - | 160,52k | -0,62% |
| 2025-12-12 | Dr. Stephen Fowler FlattCEO, President & Director | -362,00 | 0,00 | Other Disposition | - | 60,62k | -0,59% |
| 2025-12-01 | Mr. B. Anderson FlattSenior VP & Chief Information Officer | 1,35k | 86,28k | Derivative Exercise and Retained Stock | 63,96 | 14,52k | 10,24% |
| 2025-12-01 | Mr. B. Anderson FlattSenior VP & Chief Information Officer | -2,39k | 174,89k | Derivative Exercise and Sale | 63,96 - 137,29 | 14,52k | - |
| 2025-11-25 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | 860,00 | 80,93k | Derivative Exercise and Retained Stock | 94,10 | 10,61k | 8,82% |
| 2025-11-25 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | -3,14k | 137,69k | Derivative Exercise and Sale | 94,10 - 137,95 | 10,61k | - |
| 2025-11-25 | Mr. Emil E. HassanIndependent Director | -7,50k | 1,04M | Vente | 138,52 | 65,60k | -10,26% |
| 2025-11-25 | Dr. Stephen Fowler FlattCEO, President & Director | 1,85k | 99,95k | Derivative Exercise and Retained Stock | 53,94 | 60,98k | 3,13% |
| 2025-11-21 | Dr. Stephen Fowler FlattCEO, President & Director | -1 000,00 | 130,33k | Vente | 130,33 | 60,98k | -1,61% |
| 2025-11-11 | Mr. R. Michael UsseryInitié | 3,58k | 224,16k | Derivative Exercise and Retained Stock | 53,94 - 94,10 | 161,52k | 2,26% |
| 2025-11-11 | Mr. R. Michael UsseryInitié | -5,43k | 275,17k | Derivative Exercise and Sale | 53,94 - 132,20 | 161,52k | - |
| 2025-11-11 | Mr. Timothy J. ShellyInitié | 2,45k | 139,83k | Derivative Exercise and Retained Stock | 53,94 - 63,96 | 2,45k | - |
| 2025-11-11 | Mr. Timothy J. ShellyInitié | -4,75k | 354,84k | Derivative Exercise and Sale | 53,94 - 132,20 | 2,45k | - |
| 2025-11-11 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | 722,00 | 67,94k | Derivative Exercise and Retained Stock | 94,10 | 10,44k | 7,43% |
| 2025-11-11 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | -3,28k | 124,89k | Derivative Exercise and Sale | 94,10 - 132,20 | 10,44k | - |
| 2025-11-11 | Mr. Brian Frederick KiddSenior VP & CFO | 776,00 | 73,02k | Derivative Exercise and Retained Stock | 94,10 | 24,49k | 3,27% |
| 2025-11-11 | Mr. Brian Frederick KiddSenior VP & CFO | -3,22k | 122,83k | Derivative Exercise and Sale | 94,10 - 132,20 | 24,49k | - |
| 2025-11-11 | Dr. Stephen Fowler FlattCEO, President & Director | 520,00 | 48,93k | Derivative Exercise and Retained Stock | 94,10 | 60,13k | 0,87% |
| 2025-11-11 | Dr. Stephen Fowler FlattCEO, President & Director | -2,48k | 94,49k | Derivative Exercise and Sale | 94,10 - 132,20 | 60,13k | - |
| 2025-11-12 | Mr. Emil E. HassanIndependent Director | -5,50k | 731,50k | Vente | 133,00 | 73,10k | -7,00% |
| 2025-09-19 | Mr. Robert Galloway AdamsIndependent Chairman | 4,50k | 322,38k | Derivative Exercise and Retained Stock | 71,64 | 443,92k | 1,02% |
| 2025-08-22 | Dr. Stephen Fowler FlattCEO, President & Director | 854,00 | 54,78k | Derivative Exercise and Retained Stock | 53,94 - 94,10 | 59,61k | 1,45% |
| 2025-08-22 | Dr. Stephen Fowler FlattCEO, President & Director | -3,15k | 119,92k | Derivative Exercise and Sale | 53,94 - 114,82 | 59,61k | - |
| 2025-08-13 | Dr. James Paul AbernathyIndependent Director | 1,37k | 98,22k | Derivative Exercise and Retained Stock | 71,64 | 36,39k | 3,91% |
| 2025-08-13 | Dr. James Paul AbernathyIndependent Director | -2,64k | 98,12k | Derivative Exercise and Sale | 71,64 - 108,82 | 36,39k | - |
| 2025-08-13 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | 1,26k | 68,13k | Derivative Exercise and Retained Stock | 53,94 | 9,72k | 14,94% |
| 2025-08-13 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | -2,74k | 150,21k | Derivative Exercise and Sale | 53,94 - 108,82 | 9,72k | - |
| 2025-06-26 | Mr. R. Michael UsseryInitié | 2,23k | 142,44k | Derivative Exercise and Retained Stock | 63,96 | 157,95k | 1,43% |
| 2025-06-26 | Mr. R. Michael UsseryInitié | -2,01k | 90,50k | Derivative Exercise and Sale | 63,96 - 109,05 | 157,95k | - |
| 2025-06-26 | Dr. Stephen Fowler FlattCEO, President & Director | 1,18k | 75,28k | Derivative Exercise and Retained Stock | 63,96 | 58,76k | 2,04% |
| 2025-06-26 | Dr. Stephen Fowler FlattCEO, President & Director | -3,56k | 160,39k | Derivative Exercise and Sale | 63,96 - 109,05 | 58,76k | - |
| 2025-06-26 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | -788,00 | 0,00 | Other Disposition | - | 8,96k | -8,08% |
| 2025-06-12 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | 2,20k | 128,60k | Derivative Exercise and Retained Stock | 53,94 - 63,96 | 9,75k | 29,18% |
| 2025-06-12 | Ms. Vicki L. DodsonSenior VP of Patient Services & Chief Nursing Officer | -5,27k | 238,92k | Derivative Exercise and Sale | 53,94 - 104,56 | 9,75k | - |
| 2025-06-06 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | 929,00 | 59,42k | Derivative Exercise and Retained Stock | 63,96 | 8,45k | 12,35% |
| 2025-06-06 | Mr. Josh A. McCrearySenior VP, General Counsel & Secretary | -2,81k | 118,20k | Derivative Exercise and Sale | 63,96 - 106,10 | 8,45k | - |
| 2025-06-03 | Mr. Richard F. LaRocheIndependent Director | -152,00 | 15,91k | Other Disposition | 104,69 | 359,88k | -0,04% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
